21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Therapeutic compositions comprising monoterpenes
#11102Tissue kallikrein for the treatment of diseases associated with amyloid protein
#11103Recombinant poly-glutamic acid depolymerases
#11104ORGANIC CHEWABLE SUPPLEMENT
#11105Mobilization of a complete cells mixture with embryonic like stem cells from the peripheral blood
#11106HCV Combination Therapies
#11107Ethanol Enhances the Complete Replication of Hepatitis C Virus: the Role of Acetaldehyde
#11108BETA-2-GLYCOPROTEIN 1 IS AN INHIBITOR OF ANGIOGENESIS
#11109Combinations of MTP Inhibitors with Cholesterol Absorption Inhibitors or Interferon for Treating Hepatitis C
#11110METHOD OF TREATING HEPATITIS C PATIENTS
#11111Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)
#11112Linked diimidazole derivatives
#11113Linked diimidazole antivirals
#11114TREATMENT WITH ANTI-VEGF ANTIBODIES
#11115Hemostatic Composition with Magnetite
#11116Solid preparation for oral application
#11117Cytokine zalpha11 ligand antibodies
#11118METHODS COMPOSITIONS AND ARTICLE OF MANUFACTURE FOR MODULATING BONE GROWTH
#11119Somatostatin 2 receptor (sst2), deoxycytidine kinase (dck) and uridine monophosphate kinase (umk) pancreatic gene therapy
#11120Nuclease compositions and methods
#11121Methods and Compositions for the Intravenous Administration of Compounds Related to Proton Pump Inhibitors
#11122Enhanced migraine treatments based on ghrelin mimetics
#11123Pharmaceutical Composition Comprising Trospium Chloride for Once-A-Day Administration
#11124Treatment of Malignant Peripheral Nerve Sheath Tumors
#11125AMPA Receptor Antagonists and Aldose Reductase Inhibitors for Neuropathic Pain
#11126Methods of Preparing Pharmaceutical Compositions Comprising Eslicarbazepine Acetate and Methods of Use
#11127Pharmaceutical compositions-4
#11128Benzodiazepine compositions for treating epidermal hyperplasia and related disorders
#11129COMPLEXES OF PHOSPHATE DERIVATIVES
#11130Methods for concomitant administration of colchicine and macrolide antibiotics
#11131Therapeutic Cancer Treatments
#11132THERAPEUTIC AGENT FOR VITILIGO AND METHOD OF ACCELERATING PIGMENTATION
#11133Formulation to improve gastrointestinal function
#11134Compositions for enhancing the production of PPAR and/or PPAR-associated factors
#11135MIXTURE COMPRISING AN AMYLIN PEPTIDE AND A PROTRACTED INSULIN
#11136Method of screening pharmaceutical compositions that promote nuclear transfer of Cdc42 protein
#11137O-DESMETHYLVENLAFAXINE AND BAZEDOXIFENE COMBINATION PRODUCT AND USES THEREOF
#11138INSTANTLY SOLUBLE COMPOSITIONS FOR CALCIUM FORTIFICATION OF BEVERAGES
#11139USE OF SOLIDAGO VIRGAUREA IN THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS
#11140Composition For Prevention And Treatment Of Alzheimer's Disease
#11141STABLE AMORPHOUS CALCIUM CARBONATE COMPRISING SYNTHETIC PHOSPHORYLATED PEPTIDES
#11142Solid Compositions Containing Combinations of Lactoferrin, Colostrm, and Citrus Pectin
#11143Synthetic derivatives beta glycolipids and compositions thereof for the treatment of pathologic disorders
#11144PHARMACEUTICAL COMPOSITION FOR ONCE A DAY ADMINISTRATION OF TROSPIUM CHLORIDE
#11145PHARMACEUTICAL COMPOSITION FOR ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE
#11146PHARMACEUTICAL COMPOSITION FOR ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE
#11147Pharmaceutical Composition For Once-A-Day Administration of Trospium Chloride
#11148PHARMACEUTICAL COMPOSITION FOR THE ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE
#11149Functionalized nanoceria composition for ophthalmic treatment
#11150METHOD AND COMPOSITIONS FOR TREATMENT OR PREVENTION OF INFLAMMATORY CONDITIONS
#11151COMPOSITIONS INCLUDING LEUKOTRIENE ANTAGONISTS AND NSAIDS AND METHODS OF USING THE SAME
#11152FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE
#11153DIETARY SUPPLEMENT FOR HEALING OR REGRESSING SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE, GASTRITIS AND ULCERS
#11154Abuse-Resistant Pharmaceutical Dosage Form
#11155Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses Or Conditions
#11156Compositions and Methods for Improved Skin Care
#11157Encapsulated Transfer Factor Compositions and Methods of Use
#11158Wound Dressings Containing Complexes of Transition Metals and Alginate for Elastase-Sequestering
#11159Wound dressings containing complexes of transition metals and alginate for elastase-sequestering
#11160ANTIMICROBIAL COMPOSITIONS AND USES THEREOF
#11161THERAPEUTIC STEM CELL NUTRIENT COMPOSITION AND USES THEREOF
#11162CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS
#11163Method for treating stage IV melanoma
#11164High molecular weight polysaccharide that binds and inhibits virus
#11165Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
#11166PDGFR BETA-SPECIFIC INHIBITORS
#11167Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
#11168AGENTS AND METHODS FOR TREATMENT OF CANCER
#11169Methods and compositions for treating cancer
#11170Method for prevention and treatment of Alzheimer's disease
#11171ENZYME DISRUPTION OF BACTERIAL BIOFILMS
#11172COMPOSITIONS AND METHODS FOR ENHANCING NEUROPROTECTION VIA ADMINISTRATION OF STEM CELLS AND BLOOD BRAIN BARRIER PERMEABILIZERS
#11173Modulating bone growth in treating scoliosis
#11174y134.5 Deficient HSV and the MAPK Pathway
#11175Bioconversion of milk with for treatment of allergic manifestions in infants
#11176IMMUNE RESPONSE INDUCTION METHOD
#11177Compositions for treating multiple sclerosis
#11178Therapeutic composition
#11179Hepatitis C Virus inhibitors
#11180Pyridone-substituted-dihydropyrazolopyrimidinone derivative
#11181Treatment methods for fibrosis related disorders
#11182Topical foam composition
#11183Antibody therapy
#11184Hoof bath system
#11185Liquid compositions containing solubilized benzoyl peroxide, means for applying same and methods of treatment using same
#11186Nitrated-fatty acids modulation of type II diabetes
#11187Method of using abscisic acid to treat diseases and disorders
#11188ANTIDIARRHETIC COMPOSITION, PRODUCT CONTAINING THE SAME AND METHOD OF PREVENTING DIAHHREA
#11189HYDROXYTYROSOL-RICH COMPOSITION FROM OLIVE VEGETATION WATER AND METHOD OF USE THEREOF
#11190METHODS AND COMPOSITIONS FOR TREATING CANCERS
#11191MODULATION OF NEUROGENESIS USING D-CYCLOSERINE COMBINATIONS
#11192Treatment of Type 2 Diabetes With a Combination of DPIV Inhibitor and Metformin or Thiazolidinedione
#11193ANTI-TUMOR AGENT
#11194Combination Therapy for Neuroprotection
#11195PREVENTIVE AGENT OR THERAPEUTIC AGENT FOR DISEASE CAUSED BY ABNORMAL BONE METABOLISM
#11196THERAPY-ENHANCING GLUCAN
#11197MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS
#11198Azithromycin for the treatment of nodular acne
#11199USE OF THE PEPTIDE PRO-GLY-THR-CYS-GLU-ILE-CYS-ALA-TYR-ALA-ALA-CYS-THR-GLY-CYS AS A THERAPEUTIC AGENT
#11200Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
#11201Acidic Insulin Preparations Having Improved Stability
#11202Cytotoxic T cell activator comprising EP4 agonist
#11203Methods and compositions for repair of cartilage using an in vivo bioreactor
#11204Antimicrobial and antiviral composition
#11205Antioxidant Compositions, Beverage Formulations Thereof, and Methods of Increasing Antioxidant Capability
#11206NOVEL MITOCHONDRIAL UNCOUPLING METHODS AND COMPOSITIONS FOR ENHANCING ADIPOCYTE THERMOGENESIS
#11207THERAPEUTIC COMPOSITION COMPRISING OMEGA-3 POLYUNSATURATED FATTY ACID OR DERIVATIVE THEREOF, RESVERATROL AND GREEN TEA
#11208Method for treating onychoschizia
#11209Compositions and Methods for Treating Disorders Associated with Salt or Fluid Retention
#11210Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular Permeability
#11211Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
#11212Mixed metal compounds for treatment of hyperphosphataemia
#11213Natural occurring nutrient supplement compositions and methods of treatment using same by improving resistance to DNA damage, enhancing DNA repair and stimulating immune function wherein metabolic competition is avoided
#11214NUTRITIONAL SUPPLEMENT
#11215SKIN WHITENING AGENT
#11216Use of atomic quantum cluster (AQC) as antimicrobial agents and biocides
#11217Pharmaceutical Composition For Treating Nephropathy and Healthy Food Comprising Herb Extracts
#11218Composition for regulating lipid metabolism
#11219Policosanol nanoparticles
#11220Methods and compositions for treating recurrent cancer
#11221PREVENTION OF CISPLATIN INDUCED DEAFNESS
#11222TASTE-MASKED ORALLY DISINTEGRATING TABLETS OF MEMANTINE HYDROCHLORIDE
#11223Prebiotic formulations and methods of use
#11224COMBINATION PHARMACEUTICAL COMPOSITIONS
#11225Compositions for Diminishing the Appearance of Wrinkles
#11226COMPOSITIONS AND METHODS FOR COATING ORTHOPEDIC IMPLANTS
#11227Treatment of stroke and other acute neural degenerative disorders using postpartum-derived cells
#11228LACTOFERRIN AS A RADIOPROTECTIVE AGENT
#11229Compositions for suppressing obesity
#11230Combination therapy with antibody-drug conjugates
#11231METHODS OF TREATING NEOPLASTIC, AUTOIMMUNE AND INFLAMMATORY DISEASES
#11232Methods of treating dementia using a GM-CSF antagonist
#11233ANTI-INFLAMMATORY COMPOSITION COMPRISING GLYCINE AND LACTOFERRIN AND THE USE THEREOF
#11234Treatment composition comprising physically disrupted tooth pulp and non-cultured stem cells
#11235IMMUNOCYTOKINES FOR CANCER TREATMENT IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS
#11236Methods of using enterostatin as inhibitor of angiogenesis
#11237Compositions and methods for visualizing and eliminating cancer stem cells
#11238Calcium-containing restoration materials
#11239SELECTIVE INHIBITION OF HISTONE DEACETYLASES 1 AND 2 AS A TREATMENT FOR CARDIAC HYPERTROPHY
#11240Customizable Handheld Computer Data Collection System
#11241Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
#11242MAMMALIAN REPRODUCTION
#11243Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#11244Modulating the Activity of Nuclear Receptors in Order to Treat Hypoxia-Related Disorders
#11245Methods of Preventing the Serotonin Syndrome and Compositions for Use Therefor
#11246N-HALOGENATED AMINO ACID FORMULATIONS WITH ANTI-INFLAMMATORY COMPOUNDS
#11247Composition for treating a dermal anomaly
#11248SYNERGISTIC ANTI-OXIDANT TREATMENT FOR LIPOTOXICITY AND OTHER METABOLICALLY RELATED PHENOMENA
#11249Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors
#11250METHODS OF TREATMENT USING SIRT MODULATORS AND COMPOSITIONS CONTAINING SIRT1 MODULATORS
#11251COMPOSITION AND METHOD FOR TREATMENT OR PREVENTION OF BENIGN PROSTATIC HYPERPLASIA AND LOWER URINARY TRACT SYMPTOMS
#11252sGC STIMULATORS, sGC ACTIVATORS AND COMBINATIONS FOR THE TREATMENT OF UROLOGICAL DISORDERS
#11253PHARMACEUTICAL COMPOSITION COMPRISING A MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITOR AND AN ACETYLCHOLINESTERASE INHIBITOR
#11254Compositions and methods for enhancing corticosteroid delivery
#11255Compositions and methods for enhancing corticosteroid delivery
#11256COMBINATION THERAPY
#11257COMPOSITIONS AND METHODS FOR ENHANCING CORTICOSTEROID DELIVERY
#11258Therapeutic treatment
#11259METHODS AND REAGENTS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#11260Compositions Comprising 5-Amino-2-Hydroxybenzoic Acid and a Reducing Sugar
#11261Methods and Compositions for Treating Urogenital Disorders
#11262POMEGRANATE EXTRACTS, NUTRITIONAL PRODUCTS CONTAINING THEM AND THEIR USES
#11263Use of hyaluronic acid for the preparation of compositions intended for improving in particular the protective function of the skin, the eye and the mucous membranes
#11264NOVEL ANTIFOLATE COMBINATION THERAPIES
#11265METHOD AND COMPOSITION FOR TREATING PATIENTS WITH A HIGH RISK OF DEVELOPING NEURO-IMMUNE DISORDERS OR DEVELOPMENTAL DELAYS, IDENTIFIED THROUGH THE UTILIZATION OF LOW HOMOCYSTEINE OR ITS PRECURSORS/METABOLITES, AS THE PREDICTOR OF SUCH RISK
#11266COMPOUND AND COMPOSITIONS FOR TREATMENT OF DISEASE
#11267TOPICAL FORMULATIONS FOR TREATMENT OF SKIN DISORDERS
#11268USE OF A TUFTSIN AS A THERAPEUTIC AGENT
#11269USE OF IL-1 RECEPTOR PEPTIDE, ALONE OR IN COMBINATION WITH D-ALA-GLN-OCTADECYL ESTER, AS A THERAPEUTIC AGENT
#11270Neurotensin receptor agonists and opioid receptor agonists
#11271TRAP-14 AS A THERAPEUTIC AGENT
#11272MINIGASTRIN AS A THERAPEUTIC AGENT
#11273USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#11274USE OF THE PEPTIDE ASN-ASP-ASP-CYS-GLU- LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU ALONE OR IN COMBINATION WITH THE PEPTIDE THR-THR-SER-GLN-VAL- ARG-PRO-ARG AS A THERAPEUTIC AGENT
#11275COMBINATION CHEMOTHERAPY WITH CHLOROTOXIN
#11276USE OF THE PEPTIDE COMBINATION THYMOSIN BETA 4 AND DELTA SLEEP INDUCING PEPTIDE AS A THERAPEUTIC AGENT
#11277USE OF LEPTIN (22-56 ) AS A THERAPEUTIC AGENT
#11278USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#11279Peg-lipid conjugates for increasing the solubility of drug compounds
#11280Combination VEGFR2 Therapy with Temozolomide
#11281Treatment composition comprising physically disrupted tooth pulp and non-cultured stem cells in a matrix
#11282Compositions and methods of use
#11283Methods and Kits for Use in the Treatment and Prevention of Diseases or Conditions of the Immune System or Infectious Diseases
#11284Method of treating viral conditions
#11285Method of treating viral conditions
#11286TARGETED OXYGEN DELIVERY VIA INTRAVENOUS OR INTRA-ARTERIAL INFUSION OF OXYGENATED POLYMERIZED HEMOGLOBIN SOLUTIONS
#11287ANTI-ALLERGEN AGENT
#11288COMPOSITION FOR PREVENTION OR TREATMENT OF DISEASE ASSOCIATED WITH PRODUCTION OF AUTOANTIBODY
#11289ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING DOMPERIDONE AND METHODS OF USING SAME
#11290ELECTRICITY-GENERATING PARTICULATES AND THE USE THEREOF
#11291Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#11292PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
#11293Controlled release pharmaceutical formulations of nitazoxanide
#11294Formulations for treating human and animal diseases
#11295Stabilizing alkylglycoside compositions and methods thereof
#11296GALENICAL FORMULATIONS OF ORGANIC COMPOUNDS
#11297Drug releasing coatings for medical devices
#11298Color cosmetic
#11299Method for treating erectile dysfunction
#11300Antibody targeting osteoclast-related protein Siglec-15
#11301Targeting PAX2 for the treatment of breast cancer
#11302Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha
#11303Chemotherapeutic methods and compositions
#11304USE OF HYDROLYTIC AND OXIDATIVE ENZYMES TO DISSOLVE BIOFILM IN EARS
#11305BACILLUS STRAINS AND METHODS FOR REDUCING E. COLI DISEASE AND ENHANCING PERFORMANCE
#11306Herbal composition and method of use for the treatment of cancer
#11307Enhanced medical implant comprising disrupted tooth pulp and tooth particles
#11308METHOD AND PREPARATION FOR TREATING BALDNESS
#11309Biofilm treatment
#11310Stable bicarbonate ion-containing drug solution
#11311Solution and Method to Reduce, Treat and/or Prevent Oxidative Stress and Cell Activation
#11312Quinoline Derivatives as Antibacterial Agents
#11313Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone
#11314SECRETORY PHOSPHOLIPASE A2 (SPLA2) INHIBITOR AND NIACIN DRUG COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE AND DYSLIPIDEMIA
#11315Treatment for leukemia and idiopathic aplastic anemia
#11316MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
#11317TOLERABILITY OF MIRTAZAPINE AND A SECOND ACTIVE AGENT BY USING THEM IN COMBINATION
#11318DRUG FOR ALLEVIATING MOTOR COMPLICATIONS OR PSYCHIATRIC SYMPTOMS OF PARKINSON'S DISEASE
#11319Pharmaceutical Compositions and Process for Making Them
#11320NEW COMBINATIONS
#11321METHOD OF SYNERGISTICALLY ENHANCING THE THERAPEUTIC EFFICACY AND SAFETY OF MEDICATIONS THROUGH A COMBINATION THERAPY
#11322N-HALOGENATED AMINO ACID FORMULATIONS COMPRISING PHOSPHINE OR AMINE OXIDES
#11323Process for the preparation of a water-soluble complex having resveratrol compounds; products comprising said complex; and uses thereof
#11324METHODS OF TREATING HEPATIC ENCEPHALOPATHY
#11325Composition comprising extracts, compounds isolated from same, methods for preparing same and uses thereof
#11326Substrate reduction therapy
#11327COMBINATION OF SPLENOPENTIN AND THYMOPENTIN AND THE USE THEREOF IN MEDICINE
#11328USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#11329USE OF THE PEPTIDE SFLLR-OH AND MURAMYL DIPEPTIDE AS THERAPEUTIC AGENTS
#11330USE OF GLUTEN EXORPHIN C : AS A THERAPEUTIC AGENT
#11331USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#11332USE OF OCTREOTIDE AS A THERAPEUTIC AGENT
#11333(D-LEU7 ) -HISTRELIN AS A THERAPEUTIC AGENT
#11334Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women
#11335USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#11336USE OF THE PEPTIDES MAIPPKKNQDK (COW KAPPA CASEIN 106-116) AND/OR YGFQNA (SERORPHIN) AS THERAPEUTIC AGENTS
#11337GAMMA 1 MSH ALONE OR IN COMBINATION WITH PENTAGASTRIN AS A THERAPEUTIC AGENT
#11338USE OF BPP-B AS A THERAPEUTIC AGENT
#11339USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#11340THE USE OF SUBSTANCES FOR THE TREATMENT OF LOSS OF EYESIGHT IN HUMANS WITH GLAUCOMA AND OTHER DEGENERATIVE EYE DISEASES
#11341USE OF THE PEPTIDE HIS-SER-LEU-GLY-LYS-TRP-LEU-GLY-HIS-PRO-ASP-LYS-PHE ALONE OR IN COMBINATION WITH THE PEPTIDE GLY-ARD-GLY-ASP-ASN-PRO-OH AS A THERAPEUTIC AGENT
#11342DIETARY SUPPLEMENTS CONTAINING TERPENOID ACIDS OF MASLINIC ACID OR OLEANOLIC ACID AND PROCESS FOR ENHANCING MUSCLE MASS IN MAMMALS
#113434-AMINO-5-OXO-7,8-DIHYDROPYRIMIDO[5,4-F][1,4]OXAZEPIN-6(5H)-YL PHENYL DERIVATIVES
#11344USE OF GRF-1 (1-29 ) AND CORTICOTROPIN-RELEASING FACTOR AS THERAPEUTIC AGENTS
#11345USE OF A GALANIN PEPTIDE AS A THERAPEUTIC AGENT
#11346USE OF STRESSCOPIN-RELATED PEPTIDE AS A THERAPEUTIC AGENT
#11347USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#11348Method and product for treatment and/or prevention of complications of prematurity
#11349USE OF HEAT SHOCK ACTIVATORS FOR TISSUE REGENERATION
#11350SYNERGISTIC HERBAL COMPOSITION
#11351Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals
#11352DEGLYCATION OF AGEs
#11353PET FOOD COMPOSITION FOR REGULATING BODY WEIGHT AND PREVENTING OBESITY AND RELATED DISORDERS IN PETS
#11354Composition and method of treating side effects from antibiotic treatment
#11355Bone microenvironment modulated seizure treatments
#11356Methods of preventing respiratory infections
#11357COMPOSITIONS AND METHODS FOR TREATMENT OF DISORDERS OR CONDITIONS OF THE EYE
#11358Antiseptic compositions and uses thereof
#11359XENON AS A TREATMENT FOR HEMOGLOBINOPATHY
#11360Mixed metal compounds used as antacids
#11361Viruses for the treatment of cellular proliferative disorders
#11362INTERMITTENT DOSING STRATEGY FOR TREATING RHEUMATOID ARTHRITIS
#11363METHODS, COMPOSITIONS, AND KITS FOR ORGAN PROTECTION DURING SYSTEMIC ANTICANCER THERAPY
#11364FORMULATION OF MENINGITIS VACCINES
#11365Pharmaceutical Compositions Comprising NEP-Inhibitors, Inhibitors of the Endogenous Endothelin Producing System and AT1 Receptor Antagonists
#11366BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS
#11367MULTILAYERED VITAMIN COMPLEX TABLET CONTAINING UBIDECARENONE
#11368SYNERGISTIC ANTIBACTERIAL FORMULATION AND A METHOD OF MAKING THE SAME
#11369Anti-adipogenic compositions containing and
#11370Therapeutics for Cancer Using 3-Bromopyruvate and Other Selective Inhibitors of ATP Production
#11371Method for inhibiting or reducing dry eye disease by IL-1Ra
#11372COMPOSITIONS AND METHODS FOR TREATING POST-OPERATIVE PAIN USING BUPIVACAINE AND AN ANTI-ONFLAMMATORY AGENT
#11373METHOD FOR TREATING PAIN OR OPIOID DEPENDENCE USING A SPECIFIC TYPE OF NON-OPIOID AGENT IN COMBINATION WITH A SELECTIVE EXCITATORY-OPIOID-RECEPTOR INACTIVATOR
#11374Ophthalmic composition containing xanthan gum and amino acid
#11375Anti-PD-L1 antibodies, compositions and articles of manufacture
#11376METHODS OF USING CORTICOTROPIN-RELEASING FACTOR FOR THE USE OF THE TREATMENT OF CANCER
#11377TREATMENT AND DIAGNOSIS OF METASTATIC PROSTATE CANCER WITH INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)
#11378Methods for the treatment and prevention of diseases of biological conduits
#11379Orlistat compositions
#11380Sickled Erythrocytes, Nucleated Precursors & Erythroleukemia Cells for Targeted Delivery of Oncolytic Viruses, Anti-tumor Proteins, Plasmids, Toxins, Hemolysins & Chemotherapy
#11381Methods of generating, repairing and/or maintaining connective tissue in vivo
#11382Zinc-enriched biomass, method for the preparation thereof and pro-biotic, cosmetic, dietary and nutraceutic products comprising the same
#11383Cladribine regimen for treating multiple sclerosis
#11384Pregnancy hormone combination for treatment of autoimmune diseases
#11385Pathway for Th-17 Cell Development and Methods Utilizing Same
#11386Transdermal compositions
#11387METHODS FOR TREATMENT OF DERMATOLOGICAL CONDITIONS
#11388Compositions and methods for treatment of pulmonary diseases and conditions
#11389Nanoparticles for imaging and treating chlamydial infection
#11390THERAPIES FOR HEMATOLOGIC MALIGNANCIES
#11391Non-nucleotide composition for inhibiting platelet aggregation
#11392Volatile distillate by-product of mint oil that promotes absorption and/or bioavailability of compounds of bio-medical and nutritional interest
#11393Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain
#11394Transdermal compositions
#113951-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases
#11396Composition for Prevention of Hypoglycemic Condition
#11397Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury
#11398PROANTHOCYANIDINS FOR THE TREATMENT OF AMYLOID AND ALPHA-SYNUCLEIN DISEASES
#11399Synergistic combination of analgesic compounds
#11400Ischemia/reperfusion protection compositions and methods of using